Rossari Biotech Limited has submitted a regulatory disclosure to BSE Limited and the National Stock Exchange of India Limited regarding the availability of an audio recording of its earnings conference call.
The disclosure is made pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The company refers to its previous intimation letter dated July 14, 2026, regarding an earnings conference call with analysts and investors that was held on Monday, July 20, 2026.
The audio recording of this conference call is now available on the company's website at www.rossari.com/announcement-2/ under the 'Investor Call' section.
The letter requests that the exchanges take this information on record and disseminate it to all concerned parties.